Cellebrite DI Net Income
| CLBT Stock | USD 14.17 0.58 4.27% |
As of the 7th of February, Cellebrite shows the Risk Adjusted Performance of (0.04), mean deviation of 2.17, and Standard Deviation of 3.48. Cellebrite DI technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Cellebrite Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 6.3743 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -254.7 M | -242 M | |
| Net Income Applicable To Common Shares | 138.9 M | 145.9 M | |
| Net Loss | -254.7 M | -242 M | |
| Net Loss | (1.55) | (1.48) | |
| Net Income Per E B T | 0.92 | 0.97 |
Cellebrite | Net Income | Build AI portfolio with Cellebrite Stock |
The evolution of Net Income for Cellebrite DI provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Cellebrite compares to historical norms and industry peers.
Latest Cellebrite's Net Income Growth Pattern
Below is the plot of the Net Income of Cellebrite DI over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Cellebrite DI financial statement analysis. It represents the amount of money remaining after all of Cellebrite DI operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Cellebrite's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellebrite's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (283.01 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Cellebrite Net Income Regression Statistics
| Arithmetic Mean | (40,091,899) | |
| Geometric Mean | 9,447,914 | |
| Coefficient Of Variation | (280.63) | |
| Mean Deviation | 82,401,963 | |
| Median | (1,876,000) | |
| Standard Deviation | 112,508,376 | |
| Sample Variance | 12658.1T | |
| Range | 403.8M | |
| R-Value | (0.56) | |
| Mean Square Error | 9338.9T | |
| R-Squared | 0.31 | |
| Significance | 0.02 | |
| Slope | (12,371,627) | |
| Total Sum of Squares | 202530.2T |
Cellebrite Net Income History
Other Fundumenentals of Cellebrite DI
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Cellebrite Net Income component correlations
Cellebrite Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Cellebrite is extremely important. It helps to project a fair market value of Cellebrite Stock properly, considering its historical fundamentals such as Net Income. Since Cellebrite's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cellebrite's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cellebrite's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Application Software market expansion? Will Cellebrite introduce new products? Factors like these will boost the valuation of Cellebrite. Projected growth potential of Cellebrite fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Cellebrite listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share 0.38 | Revenue Per Share | Quarterly Revenue Growth 0.179 | Return On Assets |
Cellebrite DI's market price often diverges from its book value, the accounting figure shown on Cellebrite's balance sheet. Smart investors calculate Cellebrite's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Cellebrite's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cellebrite's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cellebrite should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cellebrite's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cellebrite 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cellebrite's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cellebrite.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in Cellebrite on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Cellebrite DI or generate 0.0% return on investment in Cellebrite over 90 days. Cellebrite is related to or competes with DouYu International, Lionsgate Studios, Yelp, Opera, Global IBO, Liberty Latin, and Imax Corp. Cellebrite DI Ltd. develops solutions for legally sanctioned investigations More
Cellebrite Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cellebrite's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cellebrite DI upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 25.88 | |||
| Value At Risk | (4.33) | |||
| Potential Upside | 3.91 |
Cellebrite Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cellebrite's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cellebrite's standard deviation. In reality, there are many statistical measures that can use Cellebrite historical prices to predict the future Cellebrite's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (2.20) |
Cellebrite February 7, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (2.19) | |||
| Mean Deviation | 2.17 | |||
| Coefficient Of Variation | (1,878) | |||
| Standard Deviation | 3.48 | |||
| Variance | 12.12 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (2.20) | |||
| Maximum Drawdown | 25.88 | |||
| Value At Risk | (4.33) | |||
| Potential Upside | 3.91 | |||
| Skewness | 3.27 | |||
| Kurtosis | 19.37 |
Cellebrite DI Backtested Returns
Cellebrite DI secures Sharpe Ratio (or Efficiency) of -0.0289, which signifies that the company had a -0.0289 % return per unit of risk over the last 3 months. Cellebrite DI exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cellebrite's Standard Deviation of 3.48, mean deviation of 2.17, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0889, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cellebrite's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cellebrite is expected to be smaller as well. At this point, Cellebrite DI has a negative expected return of -0.1%. Please make sure to confirm Cellebrite's maximum drawdown, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Cellebrite DI performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.66 |
Very good reverse predictability
Cellebrite DI has very good reverse predictability. Overlapping area represents the amount of predictability between Cellebrite time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cellebrite DI price movement. The serial correlation of -0.66 indicates that around 66.0% of current Cellebrite price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.66 | |
| Spearman Rank Test | -0.62 | |
| Residual Average | 0.0 | |
| Price Variance | 2.51 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Cellebrite Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Cellebrite DI reported net income of (283.01 Million). This is 152.51% lower than that of the Software sector and significantly lower than that of the Information Technology industry. The net income for all United States stocks is 149.57% higher than that of the company.
Cellebrite Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cellebrite's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cellebrite could also be used in its relative valuation, which is a method of valuing Cellebrite by comparing valuation metrics of similar companies.Cellebrite is currently under evaluation in net income category among its peers.
Cellebrite ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cellebrite's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cellebrite's managers, analysts, and investors.Environmental | Governance | Social |
Cellebrite Institutional Holders
Institutional Holdings refers to the ownership stake in Cellebrite that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Cellebrite's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cellebrite's value.| Shares | Nine Ten Capital Management Llc | 2025-06-30 | 2.1 M | Phoenix Financial Ltd | 2025-06-30 | 2 M | Millennium Management Llc | 2025-06-30 | 2 M | Bank Of America Corp | 2025-06-30 | 1.8 M | Capital Research Global Investors | 2025-06-30 | 1.7 M | Nuveen, Llc | 2025-06-30 | 1.6 M | Two Sigma Advisers, Llc | 2025-06-30 | 1.6 M | Greenhaven Road Investment Management, L.p. | 2025-06-30 | 1.5 M | Qube Research & Technologies | 2025-06-30 | 1.5 M | True Wind Capital Management, L.p. | 2025-06-30 | 13.9 M | T. Rowe Price Investment Management,inc. | 2025-06-30 | 6.5 M |
Cellebrite Fundamentals
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0524 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 2.91 B | ||||
| Shares Outstanding | 244.47 M | ||||
| Shares Owned By Insiders | 42.59 % | ||||
| Shares Owned By Institutions | 54.84 % | ||||
| Number Of Shares Shorted | 5.95 M | ||||
| Price To Earning | 82.18 X | ||||
| Price To Book | 7.62 X | ||||
| Price To Sales | 7.29 X | ||||
| Revenue | 401.2 M | ||||
| Gross Profit | 382.8 M | ||||
| EBITDA | 67.51 M | ||||
| Net Income | (283.01 M) | ||||
| Cash And Equivalents | 142.51 M | ||||
| Cash Per Share | 0.75 X | ||||
| Total Debt | 10.97 M | ||||
| Current Ratio | 1.35 X | ||||
| Book Value Per Share | 1.84 X | ||||
| Cash Flow From Operations | 132.17 M | ||||
| Short Ratio | 7.72 X | ||||
| Earnings Per Share | 0.38 X | ||||
| Price To Earnings To Growth | 13.39 X | ||||
| Target Price | 24.71 | ||||
| Number Of Employees | 1.17 K | ||||
| Beta | 1.28 | ||||
| Market Capitalization | 3.32 B | ||||
| Total Asset | 690.57 M | ||||
| Retained Earnings | (164.86 M) | ||||
| Working Capital | 272.09 M | ||||
| Net Asset | 690.57 M |
About Cellebrite Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cellebrite DI's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cellebrite using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cellebrite DI based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.